Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fhB7H3.CAR-T in Advanced Hepatocellular Carcinoma
NCT05323201Phase 2Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Feb 2022
- Primary completion
- Feb 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of fhB7H3.CAR-Ts in hepatocellular carcinoma (HCC), sponsored by The Affiliated Hospital of Xuzhou Medical University. Started Feb 2022; status: recruiting.
02
Drugs
fhB7H3.CAR-Ts
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05323201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05323201.